Eribilin Injection

उत्पाद अवलोकन

About Eribilin Injection

Eribilin Injection is a medication containing the active ingredient Eribulin Mesylate. 1 INDICATIONS AND USAGE Eribulin mesylate injection is a microtubule inhibitor indicated for the treatment of patients with: Metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Eribulin mesylate injection is a microtubule inhibitor indicated for the treatment of patients with: Metastatic breast cancer.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Eribulin Mesylate, the active ingredient in Eribilin Injection, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE Eribulin mesylate injection is a microtubule inhibitor indicated for the treatment of patients with: Metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Eribilin Injection. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Eribilin Injection for extended periods without medical advice.